Summary of China Consumer Staples 3Q25 Preview Industry Overview - The Consumer Staples sector in China is experiencing weak consumption trends in 3Q25, with easing policy headwinds but ongoing constraints on on-trade recovery [1][2] - Companies are prioritizing channel health and maintaining rational marketing investments due to weak demand, leading to volume weakness across sub-sectors [1][2] Key Insights - **Sales Growth Expectations**: An aggregated topline growth of +3%/+4% is anticipated for the Staples coverage (excluding Spirits), with beverages, pet foods, and snacks leading sales growth at 10-30% [2] - **Comparison to Previous Quarters**: This growth represents a deceleration from +5%/+7% in 2Q25, reflecting broader consumption weakness [2] - **Spirits Sector Outlook**: The spirits sector is expected to see a decline of -7%/-10% in sales/net profit, likely marking 3Q as the trough level due to stringent shipment controls [2] Company Performance - **Leaders Outperforming**: Companies like Eastroc, Nongfu, Haitian, CR Beer, Yankershop, and Weilong are expected to deliver resilient sales growth in 2H25 with higher margin visibility [2] - **Downgrade of Jonjee**: Jonjee has been downgraded to Sell from Neutral due to an 8-10% downward revision in earnings amid competitive pressure from Haitian [2] Market Trends - **September Sales Trends**: Beer and dairy sales trends improved sequentially ahead of Golden Week, while beverage and snacks showed wide divergence [2] - **Focus on Channel Health**: Companies are expected to focus on channel health and shipment control in preparation for a fresh start in 2026 [2] Future Outlook - **Investment Strategy for 2026**: Companies are expected to face diminishing cost benefits, necessitating a focus on competition and promotion strategies [8] - **Growth Drivers**: Selective snacks and beverage players are anticipated to drive topline growth through core SKU focus and POS expansion [8] - **Potential Recovery in Challenged Sectors**: Spirits valuations suggest a potential bottoming out, with recovery tied to gradual policy normalization expected in 2Q26 [8] Valuation and Shareholder Returns - **Valuation Outlook**: Investors are beginning to look into 2026/27E earnings, with pet food trading at an average of 28x/21x P/E compared to 38x for 2025 [8] - **Shareholder Return Support**: Companies like Tingyi and WH Group are noted for their attractive yields of 7-8% for 2025E/2026E [1] Conclusion - The Consumer Staples sector in China is navigating a challenging environment with weak demand and competitive pressures, but certain leaders are positioned to outperform. The focus on channel health and strategic investments will be crucial as the sector prepares for 2026.

Market Competition - India's cola market sees increased competition with the revival of homegrown brand Campa Cola by Reliance Consumer Products [1] - Campa Cola's pricing strategy involves selling 200ml bottles for 10 rupees (approximately 12 US cents), which is about half the retail price of 250ml bottles from major American cola companies [1]

Activist investors have a knack for shaking things up, pushing companies to rethink strategy, streamline operations, and unlock hidden value for shareholders. And now, beverage powerhouse Keurig Dr Pepper (KD) is in the spotlight after reports surfaced that Starboard Value, a well-known activist fund, has quietly taken a stake in the company. The news comes just months after the beverage giant’s controversial plan to acquire Dutch beverage firm JDE Peet’s (JDEPY) in August, a move that rattled investors. ...

CHARLOTTE, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (NASDAQ: COKE) will issue a news release after the market closes on October 29, 2025 to announce its operating results for the third quarter ended September 26, 2025 and the first nine months of fiscal 2025. CONTACTS: Brian K. Little (Media)Matt Blickley (Investors)Vice President, Corporate CommunicationsExecutive Vice President, Chief Financial OfficerOfficerand Chief Accounting Officer(980) 378-5537(704) 557-4910Brian.Little@c ...

Core Insights - Celsius Holdings, Inc. (CELH) is experiencing strong momentum, with stock trading near a 52-week high, reflecting investor confidence in its growth narrative [1][2] - The company has positioned itself as a dynamic player in the energy drink market through a "better-for-you" approach, global expansion, and consistent product innovation [1] Stock Performance - CELH stock closed at $61.86, close to its 52-week high of $64.81 reached on October 10, 2025 [2] - Over the past year, CELH shares have surged 83.1%, significantly outperforming the industry decline of 17.9% and the broader Zacks Consumer Staples sector's drop of 8.3% [3][8] - The company has outperformed peers such as Monster Beverage (28.1% increase), Coca-Cola (4.4% decrease), and PepsiCo (13.1% decrease) [5] Revenue Growth - In Q2 2025, Celsius generated revenues of $739.3 million, an 84% year-over-year increase, driven by the acquisition of Alani Nu and a 9% rise in the core Celsius brand [6][8] - The modern energy segment is growing rapidly, appealing to younger consumers seeking functional, zero-sugar alternatives, with household penetration rates of 34% for Celsius and 22% for Alani Nu [7] Product Innovation - Product innovation is central to Celsius' growth strategy, with limited-time flavors from Alani Nu and new fizz-free options from Celsius enhancing the product lineup [9] - Upcoming seasonal and limited-edition launches are expected to maintain brand relevance and consumer engagement [9] Geographic Expansion - North America remains the primary growth driver, but international sales increased by 27% in Q2 to $24.8 million, particularly strong in the U.K., France, and Australia [10] - The foodservice channel also showed growth, with a 9.8% volume increase, contributing approximately 12% of Celsius' North American sales through its partnership with PepsiCo [10] Valuation and Market Position - Celsius trades at a premium valuation with a forward 12-month P/E of 45.24X, significantly above the industry average of 15.07X, indicating strong growth expectations but limited room for multiple expansion [13] - Compared to other beverage leaders, Celsius' valuation is notably higher, with PepsiCo, Monster Beverage, and Coca-Cola trading at 17.95X, 32.79X, and 21.35X respectively [13] Long-term Outlook - The company is fundamentally strong and aligned with consumer trends, with disciplined execution and strong brand equity positioning it for long-term growth [17] - However, with the stock near record highs and stretched valuations, future upside may depend on continued earnings outperformance and margin resilience amid cost pressures [17]

Oct 15, 2025 11:00 AM Eastern Daylight Time Arca Continental Drives Binational Partnership To Preserve the Rio Grande River Share Coca-Cola Southwest Beverages, the U.S. business unit of Arca Continental, worked with Osprey Initiative to install two litter boom devices placed along Zacate Creek, collecting more than 2,000 pounds of waste and nearly 200 pounds of recyclable material. Across the riverbank in Nuevo Laredo, 3,000 pounds of waste has been collected, including nearly 400 pounds of recycled materi ...

Key Takeaways Tilray swung to a $1.5M profit in Q1, with revenues up 5% year over year to $209.5M.Non-cannabis segments now make up over two-thirds of total sales, led by beverages and distribution.Cannabis revenues rose 5%, driven by double-digit growth in Canadian adult-use and international markets.Last week, Tilray Brands (TLRY) reported its first-quarter results for fiscal 2026 (year ending May 2026). Both earnings and sales not only beat our expectations, but also increased from the year-ago quarter.T ...

NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today announced that it will report financial results for the third quarter ended September 30, 2025 on Wednesday, October 29, 2025 before market open. The Company will host a conference call and webcast to discuss these results at 8:30 a.m. ET on the same day. To participate in the live earnings call and question and answer ...

Key Points Target is a Dividend King retailer that is out of step today, but it is making strategic shifts that should help get customers back in its stores. PepsiCo is a Dividend King soda and snack giant that is already working to get its brand portfolio lined up with consumer trends. United Parcel Service is a turnaround story as the company works to rightsize its package delivery business. 10 stocks we like better than Target › PepsiCo (NASDAQ: PEP) has lost around 25% of its value since hitti ...

Core Insights - The article highlights three blue chip stocks that are suitable for new investors: Amazon, Coca-Cola, and Eli Lilly, emphasizing their potential for long-term growth and stability [2] Group 1: Amazon - Amazon is recognized as a leading growth stock with a market cap of $2.3 trillion, indicating significant future growth potential [3] - The company is exploring opportunities in healthcare, including the launch of prescription vending machines, which could disrupt the sector [4] - Amazon's driverless taxi business, Zoox, is in its early stages, and advancements in artificial intelligence (AI) are expected to enhance operational efficiency and customer experience [5] - Over the past four quarters, Amazon has generated $70.6 billion in profit, showcasing its strong financial performance [6] Group 2: Coca-Cola - Coca-Cola is a well-established company with a strong operational model, making it a reliable investment choice [7] - The company has successfully adapted to changing consumer preferences, with its Zero Sugar products becoming significant contributors to its portfolio [8] - Coca-Cola reported $12.2 billion in net income over the last 12 months, with a net margin of 26%, and has a dividend yield of 3%, having increased its dividend for 63 consecutive years [9] Group 3: Eli Lilly - Eli Lilly is a prominent player in the healthcare sector, particularly in the GLP-1 drug market, with products like Mounjaro and Zepbound [10] - The company is expected to introduce a GLP-1 pill next year, which could serve as a major growth catalyst [11] - Eli Lilly has a robust pipeline with numerous phase 3 trials and strong growth prospects, boasting a profit margin of around 26% [12][13]